Excel Industries Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹275 Cr +1.9% YoYSee revenue, profit and what management said. You are viewing Q3 FY26.
E

Excel Industries Ltd

Q3 FY26Chemicals & Petrochemicals

Excel Industries Q3 FY26: Revenue ₹233.5 Cr, PAT ₹8.4 Cr

Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹234Cr
+19.4% YoY
−13.3% QoQ
Net profit
₹8Cr
+33.3% YoY
−61.9% QoQ
Margin
7%
+1 pp YoY
−4 pp QoQ

Based on Excel Industries Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹950
Market cap₹1.2K Cr
P/E16.9

The short version

Q3 FY26 revenue: ₹233.5 Cr (Standalone and Consolidated), up 18.9-19% YoY from ₹196.4 Cr in Q3 FY25 (Pages 6, 8, 9) Q3 FY26 EBITDA (Adjusted): ₹16.9 Cr (Standalone ₹17.1 Cr), +29-30% YoY

From Excel Industries Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q3 FY26 revenue: ₹233.5 Cr (Standalone and Consolidated), up 18.9-19% YoY from ₹196.4 Cr in Q3 FY25 (Pages 6, 8, 9)
  • Volume growth in performance solutions driven by capacity expansion in biocides (Page 15)
  • Export revenue share: 27.0% of total revenue in Q3 FY26 (Page 5)
  • Company plans Capex of Rs. 200–300 Cr over next 3 years for plant upgrades, product innovation, capacity expansion, and technology (Page 15), indirectly supporting growth potential

Profitability & Margins

See what Excel Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Received Environmental Clearance (EC) for capacity increase and new product offerings including Phosphorus Pentasulphide, Diethyldithiophosphoryl Chloride, Diazotization Chemistry platform, Phosphonates, and Pharma capacities.
  • Upgraded waste-water treatment capabilities to handle expanded volumes.
  • Added volume capabilities for existing and new products at Vizag facility.
  • Plan to invest Rs. 200–300 Crores over next three years in plant upgrades, product innovation, capacity expansion, technology.
  • Rs. 40-50 Crores per year reserved for ongoing maintenance and improvements.
  • Introduced capacities for new products like Sodium Trichloro Pyridinol (NaTCP), polymer additive, and HEDP 4Na.
  • Technological advancements and asset maintenance ongoing at Lote and Roha sites.
  • PCL3 new plant set up at Lote in 2023.

2 more points from Excel Industries Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Excel Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The slides focus primarily on financial results, revenue, profitability, margins, shareholder returns, key personnel, and ESG principles.
  • The presentation presents historical financial performance and sustainability pillars but omits any mention of order backlog or inflow figures.

Excel Industries Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Excel Industries Ltd Q3 FY26 results — key figures

Excel Industries Ltd Q3 FY26 reported results vs Q3 FY25, ₹ crore
₹ CrQ3 FY26Q3 FY25YoYQ2 FY26QoQ
Revenue234196+19.4%270-13.3%
Operating profit (EBITDA)1612+33.3%30-46.7%
Operating margin7%6%+1 pp11%-4 pp
Profit before tax118+37.5%27-59.3%
Net profit (PAT)86+33.3%21-61.9%
EPS (₹)6.714.93+36.1%16.86-60.2%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹275 Cr, net profit ₹29 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Neochem Bio (Q3 FY26)

    Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and

  • Thirumalai Chemicals (Q3 FY26)

    Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran

  • IVP (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector

  • Gujarat Alkalies (Q3 FY26)

    3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Excel Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Excel Industries Ltd Q3 FY26 results?

Q3 FY26 revenue: ₹233.5 Cr (Standalone and Consolidated), up 18.9-19% YoY from ₹196.4 Cr in Q3 FY25 (Pages 6, 8, 9) Q3 FY26 EBITDA (Adjusted): ₹16.9 Cr (Standalone ₹17.1 Cr), +29-30% YoY

What is Excel Industries Ltd share price analysis?

Excel Industries Ltd currently shows a neutral. The stock trades at a P/E of 16.9 with a market cap of ₹1,205 Cr. Investors should review the full earnings analysis for detailed insights.

Is Excel Industries Ltd planning capital expenditure?

Received Environmental Clearance (EC) for capacity increase and new product offerings including Phosphorus Pentasulphide, Diethyldithiophosphoryl Chloride, Diazotization Chemistry platform, Phosphonates, and Pharma capacities.

Keep Excel Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.